本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ADC Therapeutics SA

1.23
+0.0000
盘后1.230.00000.00%16:30 EDT
成交量:33.44万
成交额:41.46万
市值:1.22亿
市盈率:-0.76
高:1.26
开:1.25
低:1.20
收:1.23
数据加载中...
2023/03/21

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/16

SEC问询函

Form CORRESP - Correspondence
2023/03/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/02

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/02/02

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/12/23

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/09

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/14

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/03

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/06

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]